Racial Disparities in Radiotherapy Regimens for Prostate and Breast Cancer
Black cancer patients are less likely than their White counterparts to receive shorter radiotherapy regimens, a study suggests.
Latest News
Latest News
Consolidation Regimen Deemed “Highly Active” in Relapsed/Refractory Hodgkin Lymphoma
Consolidation with up to 8 cycles of brentuximab vedotin plus nivolumab appears active in high-risk, relapsed/refractory Hodgkin lymphoma.
Serial SBRT Potentially Beneficial in Oligometastatic Prostate Cancer
Serial stereotactic body radiation therapy directed by PET using novel radiotracers may offer clinical benefits in patients with oligometastatic prostate cancer.
Convection-Enhanced Delivery of Topotecan Active in Glioblastoma
Chronic convection-enhanced delivery of topotecan was feasible and well tolerated in patients with recurrent glioblastoma.
Enzalutamide, Abiraterone Compared for mCRPC With Comorbidities
Patients with comorbidities are not routinely included in clinical trials.
Increase Seen in Years of Life Lost Per COVID-19 Death in 2021
From 2020 to 2021, COVID-19-related deaths increased among younger people.
Cancer-Related Mortality Tied to Residential Segregation
Residential racial and economic segregation across US counties is associated with higher cancer mortality, a study suggests.
Long-Term Survival With First-Line Nivolumab/Ipilimumab in NSCLC
More than one-third of patients with non-small cell lung cancer treated upfront with nivolumab plus ipilimumab were alive at 3 years.
ctDNA Surveillance Proves Challenging in Triple-Negative Breast Cancer
Using ctDNA testing to predict recurrence and guide therapy in triple-negative breast cancer is challenging, according to researchers.
Risk of Uterine Cancers Increased in Breast Cancer Patients Treated With Tamoxifen
After adjustment for confounding variables, the risk of endometrial cancer was increased almost 4-fold with tamoxifen treatment.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...